{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:14Z","timestamp":1784555234861,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024SF-YBXM-126"],"award-info":[{"award-number":["2024SF-YBXM-126"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32401188"],"award-info":[{"award-number":["32401188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2411083"],"award-info":[{"award-number":["W2411083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572430"],"award-info":[{"award-number":["82572430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515111147"],"award-info":[{"award-number":["2023A1515111147"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["ZYTS25094"],"award-info":[{"award-number":["ZYTS25094"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["QTZX25107"],"award-info":[{"award-number":["QTZX25107"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T180787"],"award-info":[{"award-number":["2025T180787"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2421000"],"award-info":[{"award-number":["2024YFC2421000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFB3203800"],"award-info":[{"award-number":["2022YFB3203800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005320","name":"Xidian University","doi-asserted-by":"publisher","award":["TZJH2024041"],"award-info":[{"award-number":["TZJH2024041"]}],"id":[{"id":"10.13039\/501100005320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xcrm.2025.102523","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:06:35Z","timestamp":1766160395000},"page":"102523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases"],"prefix":"10.1016","volume":"7","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichenxi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-149X","authenticated-orcid":false,"given":"Zhongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102523_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-021-00603-1","article-title":"Immune-mediated inflammatory disease therapeutics: past, present and future","volume":"21","author":"McInnes","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102523_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103410","article-title":"Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features","volume":"22","author":"Monteleone","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.xcrm.2025.102523_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(19)31772-6","article-title":"Psoriasis biologics: a new era of choice","volume":"394","author":"Mahil","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102523_bib4","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240806","article-title":"Targeting TNF\/TNFR superfamilies in immune-mediated inflammatory diseases","volume":"221","author":"Veerasubramanian","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102523_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41573-020-0078-4","article-title":"Soluble ligands as drug targets","volume":"19","author":"Attwood","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102523_bib6","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jaad.2025.06.019","article-title":"Disease modification in psoriasis through early interleukin 17 inhibitor intervention: A retrospective cohort study","volume":"93","author":"Chen","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.xcrm.2025.102523_bib7","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00296-023-05458-4","article-title":"First multi-center retrospective study assessed the compliance with and persistence of biological therapies in Bulgarian population with rheumatoid arthritis","volume":"43","author":"Neycheva","year":"2023","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.xcrm.2025.102523_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12817","article-title":"Injection site reactions with the use of biological agents","volume":"32","author":"Thomaidou","year":"2019","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.xcrm.2025.102523_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-eular.3106","article-title":"AB0784 Adherence rate to conventional dmards in patients with rheumatoid arthritis using biologics in a real-life setting","volume":"72","author":"Santos-Moreno","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.xcrm.2025.102523_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/annrheumdis-2015-eular.1468","article-title":"THU0142 Prediction of non-adherence in patients with rheumatoid arthritis","volume":"74","author":"Choquette","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.xcrm.2025.102523_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrrheum.2016.137","article-title":"The global burden of SLE: prevalence, health disparities and socioeconomic impact","volume":"12","author":"Carter","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.xcrm.2025.102523_bib12","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2501635122","article-title":"Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling","volume":"122","author":"Ota","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102523_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102523_bib14","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.cell.2024.05.052","article-title":"Preclinical proof of principle for orally delivered Th17 antagonist miniproteins","volume":"187","author":"Berger","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102523_bib15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1056\/NEJMoa2308713","article-title":"An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis","volume":"390","author":"Bissonnette","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102523_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.mattod.2023.01.002","article-title":"Oral drug delivery platforms for biomedical applications","volume":"62","author":"Ouyang","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.xcrm.2025.102523_bib17","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1021\/acsnano.2c09266","article-title":"Oral delivery of therapeutic antibodies with a transmucosal polymeric carrier","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102523_bib18","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41565-024-01764-5","article-title":"An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs","volume":"19","author":"Ji","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2025.102523_bib19","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.matt.2021.08.011","article-title":"Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes","volume":"4","author":"Xiao","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.xcrm.2025.102523_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2025.102523_bib21","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3389\/fphar.2018.01571","article-title":"Microbial-based therapies in the treatment of Inflammatory bowel disease - an overview of human studies","volume":"9","author":"Basso","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102523_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.20180448","article-title":"The gut microbiome: Relationships with disease and opportunities for therapy","volume":"216","author":"Durack","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102523_bib23","doi-asserted-by":"crossref","first-page":"AP238","DOI":"10.1161\/circ.137.suppl_1.p238","article-title":"Abstract P238: Remission\/cure of autoimmune diseases by a lectin limite diet supplemented with probiotics, prebiotics, and polyphenols","volume":"137","author":"Gundry","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2025.102523_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412982","article-title":"Engineered bacteria manipulate cysteine metabolism to boost ferroptosis-based pancreatic ductal adenocarcinoma therapy","volume":"37","author":"Qiao","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.102523_bib25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","article-title":"Developing a new class of engineered live bacterial therapeutics to treat human diseases","volume":"11","author":"Charbonneau","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102523_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.chom.2023.03.007","article-title":"Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut","volume":"31","author":"Lynch","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2025.102523_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2399213","article-title":"Empowering probiotics with high xanthine transport for effective hyperuricemia management","volume":"16","author":"Zou","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.xcrm.2025.102523_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.chom.2019.02.005","article-title":"Adaptive strategies of the candidate probiotic E.coli Nissle in the mammalian gut","volume":"25","author":"Crook","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2025.102523_bib29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/gutjnl-2020-321173","article-title":"Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis","volume":"70","author":"Pujo","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2025.102523_bib30","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.cell.2016.11.044","article-title":"IL-17 Blockade in Psoriasis","volume":"167","author":"Burkett","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102523_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106568","article-title":"Secretion and surface display of binders of IL-23\/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation","volume":"190","author":"Plavec","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.xcrm.2025.102523_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12934-017-0701-1","article-title":"Efficient extracellular recombinant production and purification of a Bacillus cyclodextrin glucanotransferase in Escherichia coli","volume":"16","author":"Sonnendecker","year":"2017","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.xcrm.2025.102523_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12403-023-00578-5","article-title":"Increased intestinal permeability: an avenue for the development of autoimmune disease?","volume":"16","author":"English","year":"2024","journal-title":"Expo. Health"},{"key":"10.1016\/j.xcrm.2025.102523_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216352","article-title":"The relationships between intestinal permeability and target antibodies for a spectrum of autoimmune diseases","volume":"24","author":"Kharrazian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102523_bib35","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102523_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2019.12.016","article-title":"Polypeptide-corticosteroid conjugates as a topical treatment approach to psoriasis","volume":"318","author":"Dolz-P\u00e9rez","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.xcrm.2025.102523_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2025.102523_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41587-021-01024-0","article-title":"Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors","volume":"40","author":"Abramson","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102523_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/protein\/gzp073","article-title":"Engineering of stable bispecific antibodies targeting IL-17A and IL-23","volume":"23","author":"Mabry","year":"2010","journal-title":"Protein Eng. Des. Sel."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:50:00Z","timestamp":1776207000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125005968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666379125005968"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102523","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102523"}}